Projected Income Statement: cbdMD, Inc.

Forecast Balance Sheet: cbdMD, Inc.

Fiscal Period: September 2021 2022 2023 2024 2025 2026 2027
Net Debt -26.2 - - - - - -
Change - - - - - - -
Announcement Date 12/17/21 12/15/22 12/22/23 12/18/24 12/19/25 - -
Estimates

Cash Flow Forecast: cbdMD, Inc.

Fiscal Period: September 2020 2021 2022 2023 2024 2025
CAPEX 1 1.32 0.342 0.6887 0.2975 0.19 0.1842
Change - -74.09% 101.36% -56.79% -36.14% -3.08%
Free Cash Flow (FCF) 1 -5.318 -7.479 -9.38 -0.6158 5.776 -4.925
Change - -40.63% -25.42% 93.44% 1,038.04% -185.26%
Announcement Date 12/22/20 12/17/21 12/15/22 12/22/23 12/18/24 12/19/25
1USD in Million
Estimates

Forecast Financial Ratios: cbdMD, Inc.

Fiscal Period: September 2020 2021 2022 2023 2024 2025 2026 2027

Profitability

        
EBITDA Margin (%) - -41.81% - - - - - -
EBIT Margin (%) - -44.1% - -22.88% -8.17% -4.74% -6.92% -2.38%
EBT Margin (%) - -54.61% - -94.96% -18.99% -10.63% -6.91% -2.38%
Net margin (%) - -58.34% - -111.53% -39.54% -10.63% -8.5% -4.12%
FCF margin (%) - -32.45% - - - - - -
FCF / Net Income (%) - 55.63% - - - - - -

Profitability

        
ROA -10.4% -10.4% -13.06% -20.33% -15.48% -12.87% - -
ROE 21.67% -25.66% -104.16% -113.4% -67.31% -44.42% - -

Financial Health

        
Leverage (Debt/EBITDA) - - - -0.25x - - - -
Debt / Free cash flow - - - -3.06x - - - -

Capital Intensity

        
CAPEX / Current Assets (%) - 0.77% - 1.23% - - - -
CAPEX / EBITDA (%) - -1.84% - - - - - -
CAPEX / FCF (%) - -2.37% - - - - - -

Items per share

        
Cash flow per share 1 - - - - - - - -
Change - - - - - - - -
Dividend per Share 1 - - - - - - - -
Change - - - - - - - -
Book Value Per Share 1 - - - - - - - -
Change - - - - - - - -
EPS 1 - -169.2 -446.4 -106.6 -14.32 -1.09 -0.14 -0.07
Change - - -163.83% 76.13% 86.56% 92.39% 87.16% 50%
Nbr of stocks (in thousands) - 160 168 357 480 8,913 10,496 10,496
Announcement Date - 12/17/21 12/15/22 12/22/23 12/18/24 12/19/25 - -
1USD
Estimates
2026 *2027 *
P/E ratio -5.56x -11.1x
PBR - -
EV / Sales 0.39x 0.36x
Yield - -

EPS & Dividend

Y-o-Y evolution of P/E

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
0.7790USD
Average target price
2.000USD
Spread / Average Target
+156.74%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. YCBD Stock
  4. Financials cbdMD, Inc.